Objective: To study the immunohistochemical pattern of CD 117, glial fibrillary acidic protein (GFAP), smooth muscle actin (SMA) and CD 43 in pleomorphic adenoma (PA), adenoid cystic carcinoma (AdCC) and polymorphous low grade adenocarcinoma (PLGA) of minor salivary glands. Materials and Methods: Twenty cases of PA, 20 cases of AdCC and 10 cases of PLGA were retrieved from record files along with their paraffin blocks at Armed Forces Institute of Pathology, Pakistan. New histological diagnosis was made on freshly prepared H&E sections followed by application and analysis of immunostains. Results: The mean age of the patients was 44 ± 15 (mean SD) (range; 17-86) years. There were 26 male and 24 female patients with a male to female ratio of 1.08:1. Fourteen cases of PA, 14 cases of AdCC and 6 cases of PLGA were positive for CD117. In case of GFAP, only 9 cases of AdCC and 3 cases of PLGA were positive; however, 16 cases of PA were also positive. Twelve cases of AdCC and 7 cases of PA were positive for SMA and half of the PLGA cases were also reactive. Nonetheless, the least expression was seen in case of CD 43, where only five cases of AdCC were positive. Six cases of PA and three cases of PLGA were also positive. Conclusion: Our results suggest that the use of GFAP, SMA, CD 117 and CD 43 as an adjunct to histological examination is not helpful in differentiating PA, AdCC and PLGA from one another.
INTRODUCTION
Salivary gland tumors make up 3-4% of all head and neck tumors [1] . Moreover, there is an overall increase in the incidence of salivary gland tumors worldwide, irrespective of the etiologic factor [2] [3] [4] [5] . Neoplasms of the minor salivary glands in contrast to the major salivary glands are rare, representing 10-15% of all salivary gland tumors [6] . Common malignant tumors of minor salivary glands include adenoid cystic carcinoma, mucoepidermoid carcinoma and polymorphous low-grade adenocarcinoma, while pleomorphic adenoma is the most common benign tumor [1, 4, [7] [8] [9] . Parotid is the most common site of major salivary gland tumors, and the palate is the commonest site for minor salivary glands [1, 3, 5, 7] . Salivary gland tumors can express a wide array of morphological variety between different tumors and at times within a single tumor. Moreover, hybrid tumors, anaplasia and tendency for few benign tumors to transform into malignancy can lead to histopathological misinterpretation [10] . With passing time, Immunohistochemistry (IHC) has become an essential aid for pathologists and serves as an important adjunct for diagnosis [11] [12] [13] . The role of IHC is enhanced when the diagnosis of minor salivary gland tumors becomes problematic on routine H&E stain as a result of loss of characteristic histopathological features in an incisionally biopsied or fragmented biopsy sample. Multiple studies have been performed to investigate the role of immunomarkers in salivary gland tumors. A large number of studies have evaluated the role of CD 117 (c-kit) and smooth muscle actin (SMA) in differentiating AdCC from PLGA [13-17], while glial fibrillary acidic protein (GFAP) seems promising in differentiating between PA and PLGA [12, [18] [19] [20] . In salivary gland pathology, lot many antibodies have been applied to analyse different tumor cell types in order to establish differences among tumor types and highly variable results have been reported. In this study, we analysed the immunohistochemical pattern of pleomorphic adenoma, adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma that bear histological similarity on routine H&E stain. In such cases, it is critical to make a definite diagnosis as each of these tumors has an entirely different treatment protocol. We applied a panel of four immunomarkers including CD117, CD43, SMA and GFAP; these antibodies are the most commonly used in worldwide literature; however, conflicting results were reported, this compelled us to explore their useful potential in the diagnostic efficacy of the mentioned tumors. Moreover, not a single study has ever been carried out in our setup that has looked for a pattern of immunomarkers in SGT. Thus, there is a need for lot more research in the respective subject to reach a definite diagnosis and in turn to deliver a right therapy protocol to the patient.
MATERIALS AND METHODS
The study design is retrospective descriptive in which a total of 50 cases were retrieved from record files along with their paraffin embedded sections. These included 20 cases of PA, 20 cases of AdCC and 10 cases of PLGA. The data on gender, age and the site of involvement were extracted from the clinical histories in each case. Histological features of all the selected cases were reviewed from freshly prepared H&E sections and the new diagnosis regardless of the previous diagnosis was made by one consultant histopathologist. In cases that there was difference with the original diagnosis, the case was also reviewed by a second histopathologist to confirm the revised diagnosis.For each tumor type, 4 µm thick tissue sections with microtome were taken and placed on charged slides (vectabond). Immunohistochemical staining was performed by mouse monoclonal antibodies manufactured by Thermo Fisher Scientific company and the streptavidin biotin technique was applied. The clone designation of immunomarkers was as follows:
 CD 43 (84-3C1) For SMA, CD 43 and GFAP, microwave heatinduced epitope retrieval was performed using citrate buffer (pH 6.0). For CD 117, pressure cooker induced epitope retrieval was performed as advised by the manufacturer. All incubations were done in the humidity chamber. Positive controls for every marker were also stained as advised by the manufacturer.
1. Skin for CD 117 2. Brain for GFAP 3. Bowel wall for SMA 4. Tonsil for CD 43 The immunoreactivity was considered positive if greater than 10% of the tumor cells were stained. Positivity was graded according to the percentage of tumor cells stained as weak (10-25%), moderate (25-50%) and strong (50-100%). This criterion is being used by Andreadis et al. and Woo et al.; and was taken as reference for the present study [11, 21] .
RESULTS
The mean age of the patients was 44 ± 15 (mean SD) (range, 17-86) years. There were 26 male and 24 female patients with a male to female of 1.08:1. The most common site of tumor presentation was the palate making up 58% of the cases followed by the maxillary ridge (14%) and the tongue (6%). The detailed results of positive or negative expression of immunomarkers in the three tumor types are summerized in Table 1 .
Photomicrographs of all immunostains in the three tumor types are shown in Figure 1 
DISCUSSION
Various studies have been conducted worldwide to analyze the pattern of different immunomarkers in salivary gland tumors that pose diagnostic difficulty because of histologic similarities. In the present study, regarding the expression of CD 117, in most of the positive cases, of either the PA or tubular type of AdCC, the inner luminal cells were diffusely reactive with CD 117 and only in a few cases, diffuse staining was observed with no discrimination between the luminal and abluminal cells. The diffuse staining pattern was more pronounced in cases of AdCC with solid or cribriform histological subtypes. However, no such pattern was appreciated by PLGA, probably because of its diverse histological morphology.
As per results, we can make out that CD 117 expression was almost the same in AdCC and PA, thus practically of no use in distinguishing the two tumors based on the percentage of positive cases. However, the percentage of positive cells was variable as 60% of PA's and 80% of AdCC being scored as 3+ (> 50% cells positive), respectively. The rest of the cases had less than 50% tumor cell positivity [22] .
Immunoreactivity and Staining Intensity
Thus, in accordance with these studies; we can conclude that CD 117 is not a useful marker in the differential diagnosis of AdCC and PA. Moreover, regarding the expression of CD 117 in differentiating AdCC from PLGA, again varying results are reported. In a study conducted by Andreadis et al., seven out of 14 cases (50%) of PLGA were entirely negative for the marker and in the rest of the positive cases; none showed more than 50% positivity [21] . In 2002, in a similar study performed by Penner et al., 100% of AdCC (9/9) were positive in which most of the cases (7/9) had more than 50% cells positive with CD 117. However, 57% of PLGA (8/14) were reactive for the particular immunomarker, but none of the cases showed more than 50% positivity [14] . Likewise, in year 2007 in a study carried out by Epivatianos et al., 83% of AdCC (10/12) and 41% of PLGA (5/12) were positive. Here again, the major difference lies in the number (n=10) were positive for the marker and all cases of AdCC (n=8) were negative for GFAP. Tissue followup confirmed the diagnosis of PA and AdCC in all cases. Subsequent tissue follow-up in these cases revealed 4 cases of AdCC negative and 4 cases of PA positive for GFAP. So if we calculate the significance value by summing up the results of tissue sections of all the cases, it turns to be very significant (p=0.0027) [25] . The role of neoplastic myoepithelium in the histogenesis of various salivary gland tumors has been explored worldwide; however, controversy still exists. The role of SMA in differentiating AdCC from PLGA has been reported in the medical literature. An American study conducted by Prasad et al. established the myoepithelial differentiation in all cases of AdCC (n=13) included in their study, in contrast to which none of the PLGA (n=26) showed positive reactivity to SMA. Their results showed a very significant statistical p value (p<0.0001). The staining in case of AdCC was more pronounced in the outer layer of the tubular structures of tubular subtype as compared to cribriform and solid subtypes [26] . On the other hand, in case of pleomorphic adenoma, myoepithelial cells make a good amount of tumor cells, which in turn impart positive reaction to myoepithelial markers including SMA. A very convincing study carried out in 1997 by Savera et al. [28] showed that 94% of the cases were positive for SMA. But the results of our study are contrary to this study, as eight out of 20 cases were entirely negative, ten had less than 50% of the tumor cells positive and only two cases had more than 50% tumor cell positivity (all the cases had positive internal control 
CONCLUSION
In conclusion, the expression of the immunomarkers was not restricted to any specif-ic tumor type and the histopathological features on routine H&E are the gold standard for diagnosing tumors with somewhat equivocal histological features. Moreover, differences of results worldwide may be attributed to the technique sensitivity of IHC leading to false positive and false negative results
